Related Experiment Video

Updated: May 23, 2026

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay
11:38

Visualization and Quantification of TGFβ/BMP/SMAD Signaling under Different Fluid Shear Stress Conditions using Proximity-Ligation-Assay

Published on: September 14, 2021

Scleraxis modulates bone morphogenetic protein 4 (BMP4)-Smad1 protein-smooth muscle α-actin (SMA) signal transduction

Hideharu Abe1, Tatsuya Tominaga, Takeshi Matsubara

  • 1Department of Nephrology, Institute of Health Biosciences, University of Tokushima Graduate School of Medicine, Tokushima 770-8503, Japan. abeabe@clin.med.tokushima-u.ac.jp

The Journal of Biological Chemistry
|April 5, 2012
PubMed

Insights

Scleraxis (Scx) modulates mesangial cell differentiation in diabetic nephropathy by regulating smooth muscle α-actin (SMA) expression. Scx and Id1 are key players in the BMP4-Smad1-SMA pathway, impacting renal disease progression.

Area of Science:

  • Nephrology
  • Cell Biology
  • Molecular Biology

Background:

  • Mesangial cell (MC) activation, marked by smooth muscle α-actin (SMA) expression, is crucial in renal diseases.
  • Mechanisms governing MC differentiation remain incompletely understood.

Purpose of the Study:

  • To identify novel regulators of MC differentiation in the context of advanced glycation end product (AGE) exposure.
  • To elucidate the role of scleraxis (Scx) in modulating SMA expression and MC phenotype.

Main Methods:

  • Investigated Scx's interaction with SMA promoter elements.
  • Assessed the impact of Scx on bone morphogenetic protein 4 (BMP4) and Smad1 signaling.
  • Examined Scx and SMA expression in diabetic mouse models.
  • Analyzed the role of inhibitor of differentiation 1 (Id1) in Scx-mediated regulation.

Main Results:

  • Scx directly binds to the SMA promoter and negatively regulates AGE-induced SMA expression.
  • Scx induces BMP4, which controls Smad1 activation in AGE-treated MCs.
  • Scx and SMA are co-expressed in glomeruli of diabetic mice; Id1 dislodges Scx from the SMA promoter.

Conclusions:

  • Scx and Id1 are integral components of the BMP4-Smad1-SMA signaling pathway.
  • This pathway, alongside TGFβ1-Smad1-SMA, modulates MC phenotypic changes in diabetic nephropathy.
  • Scx represents a potential therapeutic target for diabetic kidney disease.

More Related Videos

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation08:43

Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation

Published on: May 31, 2016

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...